Focusd on improving patient care Sympano is a medical diagnostic and point-of-care device company leveraging nanotechnology sensitively to measure patient biomarkers faster, for lower cost and greater sensitively than current standards. The form of nanotechnology enagged greatly increases the surface area for nanoscale binding events that are measured with changes of impedance which are then correlated to a concentration of the target biomarker. Though relevant across various applications, Sympano's work is initially focused on pneumonia: he second cause of death overall - and the first among pre-school aged children under 5 years old - as well as a primary cause of sepsis. The capacity to diagnose - and/or screen for - pneumonia quickly and on site versus with a test requiring lab analysis. the technology could shift pneumonia from the current qualitative result to a quantitative reading. From a drop of blood, urine, and/or saliva detection of common causes of pneumonia could be achieved
